Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1988-04-18
1990-04-24
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 71, 536 72, A61K 3170, C07H 1708
Patent
active
049201026
ABSTRACT:
Novel ring-contracted macrolides which enhance gastrointestinal motility and novel methods and compositions for treating gtastrointestinal disorders in animals with these macrolides and with certain other previously known ring-contracted macrolides are provided.
REFERENCES:
patent: 4547491 (1985-10-01), Mrozik et al.
patent: 4677097 (1987-06-01), Omura et al.
Z. Itoh et al., "Erythromycin Mimics Exogenous Motilin in Gastrointestinal Contractile Activity in the Dog," Am. J. Physiol. 247, G688-694, (1984).
M. A. Pilot et al., "Alterations in Gastrointestinal Motility Associated with Erythromycin," Brit. J. Pharmacolog. 81, 168P, (1984).
S. Omura et al., "Gastrointestinal (GI) Motor-Stimulating Activity of Erythromycin Derivatives," Interscience Conference on Antimicrobial Agents and Chemotherapy (ICCAAC) meeting, 1985.
S. Omura et al., "Gastrointestinal Motor-Stimulating Activity of Macrolide Antibiotics and the Structure-Activity Relationship", J. Antibiotics 38 (11), 1631-1632, (1985).
S. Omura et al., "Macrolides with Gastrointestinal Motor Stimulating Activity," J. Med. Chem 30 (11), 1941-1943, (1987).
S. Omura, "Motilide, A Series of Macrolides with Gastrointenstinal Motor Stimulating Activity," Abstract from Japanese-U.S. Congress of Pharmaceutical Sciences Meeting, 1987.
B. L. Carter, et al., "Gastrointestinal Side Effects with Erythromycin Preparation," Drug. Intell. & Clin. Pharmacy 21, 734-738, (1987).
Z. Itoh et al., "Gastrointestinal Motor-Stimulating Activity of Macrolide Antibiotics and Analysis of Their Side Effects on the Canin Gut," Antimicrob Ag. Chemotherap. 26 (6), 863-869, (1984).
Z. Itoh et al., "Structure-Activity Relation Among Macrolide Antiobiotics in Initiation of Interdigestive Migrating Contractions in the Canine Gastrointestinal Tract", Am. J. Physiol. 248, G320-G325, (1985).
X. Y. Qin, et al., "Comparison of the Side Effects and Gastrointestinal Motility Observed after Administration of Erythromycin and Josamycin to Dogs," J. Antimicrob. Chemotherapy 18, 747-756, (1986).
M. A. Pilot, et al., "Macrolides and Gastrointestinal Motility," ibid. 22, Suppl. B, 201-206, (1988).
T. Tomomasa, et al., "Erythromycin Induces Migrating Motor Complex in Human Gastrointestinal Tract," Digestive Diseases & Sciences 31 (2), 157-161, (1986).
Z. Itoh, et al., "Motilide, A New Family of Macrolide Compounds Mimicing Motilin," Abstr., 11th Internatl. Symposium on Gastrointestinal Motility, Oxford, England, Sept. 7-11, 1987, p. 915.
Y. Kondo, et al., "Erythromycin and its Derivatives with Motilin-Like Biological Activities Inhibit the Specific Binding of .sup.125 I-Motilin to Duodenal Muscle," Biochem. Biophys. Res. Commun. 150, 877-882, (1988).
I. Depoortere, et al., "Macrolinde Antiobiotics are Motiling Receptor Agonists," Heptao-Gastroenterol, 35, 198, (1988).
T. Nakayoshi, et al., "Comparative Study of Effects of 14-and 16-Membered Macrolides on Gastrointestinal Motility in Unanesthetized Dogs," Drugs Exptl. Clin. Res. 14 (5), 319-325, (1988).
Y. Tanaka, et al., "Radioimmuno Assay for Erythromycin Derivatives," J. Antibiotics 41 (2), 258-260, (1988).
I. O. Kibwage, et al., "Translactionization in Erythromycin," J. Org. Chem. 52, 990-996, (1987).
I. O. Kibwage, et al., "Identification of Novel Erythromycin Derivatives in Mother Liquor Concentrates of Streptomyces Erythraeus," J. Antibiotics 40 (1), 1-6, (1987).
H. A. Kirst, et al., "Synthesis of Ring-Contracted Derivatives of Erythromycin," J. Org. Chem. 52, 4359-4362, (1987).
S. N. Heyman et al., "Erythromycin-Induced Dynamic Ileus?" J. Clin. Gastrointerol 10 (4), 551-554, (1988).
Kitasato Kenkyusho, Derivent Abstract 87-066334/10, Abstracting EPO Application 213,617A, "Digestive Tract Contractile Motion Stimulent with Low Toxicity Comprises Erythromycin A, B, C, D or E Deriv."
Gidda Jaswant S.
Kirst Herbert A.
Robertson David W.
Eli Lilly and Company
Harrison Nancy J.
Peselev Elli
Rollins John W.
Whitaker Leroy
LandOfFree
Method for treating gastrointestinal disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating gastrointestinal disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating gastrointestinal disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-34796